Evaluate the Side Effects and Benefits of RAS 130 With or Without Diet and Exercise in Type II Diabetes Mellitus

PHASE2UnknownINTERVENTIONAL
Enrollment

460

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Type II Diabetes Mellitus
Interventions
OTHER

RAS 130 with diet and exercise

Entire population, which will also include existing patients, will be treated with RAS 130 along with diet and exercise. By the end of 6 months: 3 months of study and 3 months of follow-up, the entire population will be divided into two groups which will be determined through endpoints. The first group will be subjects with diet and exercise and the second group will be subjects without diet and exercise. The endpoints for the division of the groups are given in the design of the study.

Trial Locations (5)

08816

MedCenter, East Brunswick

08901

Robertwood Johnson Hospital, New Brunswick

08861

Raritan Bay Medical Center, Perth Amboy

Unknown

Sri Ramachandra University, Porur

Dr. JL Rohatagi Hospital, Sarvoday Nagar, Kanpur

All Listed Sponsors
collaborator

Proactive Clinical Research

UNKNOWN

lead

American Scitech International

OTHER